Drug Profile
Research programme: antifungals - Thallion Pharmaceuticals
Alternative Names: Antifungals research programme - Thallion Pharmaceuticals; ECO 02301 class; ECO-02301; ECO-14401; ECO-4401Latest Information Update: 26 Aug 2009
Price :
$50
*
At a glance
- Originator Ecopia BioSciences
- Class Macrolides; Polyenes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 26 Aug 2009 No development reported - Preclinical for Mycoses in Canada (unspecified route)
- 30 Jan 2003 Preclinical trials in Mycoses in Canada (unspecified route)